Literature DB >> 29428983

Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia.

Carlo Cervellati1, Alessandro Trentini2, Cristina Bosi3, Giuseppe Valacchi4,5, Mario Luca Morieri6, Amedeo Zurlo3, Gloria Brombo6, Angelina Passaro6, Giovanni Zuliani7.   

Abstract

The decline in basic and instrumental activities of daily living (BADLs and IADLs, respectively) is a well-established clinical hallmark of dementia. Growing evidence has shown that systemic subclinical inflammation may be related to functional impairment. We evaluated the possible association between low-grade systemic inflammation and functional disability in older individuals affected by dementia. We explored the association between high-sensitivity C-reactive protein (hs-CRP) levels and BADLs/IADLs in older individuals affected by late onset Alzheimer's disease (LOAD; n 110), "mixed" dementia (n 135), or mild cognitive impairment (MCI; n 258), and compared them with 75 normal Controls. Independent of age, gender, comorbidity, and other potential confounders, higher hs-CRP was significantly associated with poorer BADLs (loss ≥ 1 function) in people with LOAD (odds ratio [OR] 3.14, 95% confidence interval [CI], 1.33-7.33) and mixed dementia (OR 2.48, 95%CI 1.12-5.55), but not in those with MCI (OR 1.38, 95%CI 0.83-2.45) or Controls (OR 2.98, 95%CI 0.54-10.10). No association emerged between hs-CRP and IADLs in any of the sub-group. Our data suggest that systemic low-grade inflammation may contribute to functional disability in older patients with dementia.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Functional abilities; Inflammation; Mixed dementia

Mesh:

Substances:

Year:  2018        PMID: 29428983      PMCID: PMC5832662          DOI: 10.1007/s11357-018-0010-6

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  31 in total

1.  Functional evaluation distinguishes MCI patients from healthy elderly people--the ADCS/MCI/ADL scale.

Authors:  H Pedrosa; A De Sa; M Guerreiro; J Maroco; M R Simoes; D Galasko; A de Mendonca
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.

Authors:  Carlo Cervellati; Arianna Romani; Davide Seripa; Eleonora Cremonini; Cristina Bosi; Stefania Magon; Angelina Passaro; Carlo M Bergamini; Alberto Pilotto; Giovanni Zuliani
Journal:  J Neurol Sci       Date:  2013-12-04       Impact factor: 3.181

3.  Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons.

Authors:  David B Reuben; Anna I Cheh; Tamara B Harris; Luigi Ferrucci; John W Rowe; Russell P Tracy; Teresa E Seeman
Journal:  J Am Geriatr Soc       Date:  2002-04       Impact factor: 5.562

4.  Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging.

Authors:  Deborah M Kado; Alexander Bucur; Jacob Selhub; John W Rowe; Teresa Seeman
Journal:  Am J Med       Date:  2002-11       Impact factor: 4.965

5.  PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia.

Authors:  Carlo Cervellati; Arianna Romani; Carlo M Bergamini; Cristina Bosi; Juana Maria Sanz; Angelina Passaro; Giovanni Zuliani
Journal:  Clin Chem Lab Med       Date:  2015-06       Impact factor: 3.694

6.  Functional decline in cognitive impairment--the relationship between physical and cognitive function.

Authors:  Tung Wai Auyeung; Timothy Kwok; Jenny Lee; Ping Chung Leung; Jason Leung; Jean Woo
Journal:  Neuroepidemiology       Date:  2008-09-11       Impact factor: 3.282

Review 7.  OxInflammation in Rett syndrome.

Authors:  Alessandra Pecorelli; Carlo Cervellati; Joussef Hayek; Giuseppe Valacchi
Journal:  Int J Biochem Cell Biol       Date:  2016-07-15       Impact factor: 5.085

8.  Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project.

Authors:  E Mariani; R Monastero; S Ercolani; P Rinaldi; F Mangialasche; E Costanzi; D F Vitale; U Senin; P Mecocci
Journal:  Int J Geriatr Psychiatry       Date:  2008-05       Impact factor: 3.485

9.  Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.

Authors:  Katrin Jekel; Marinella Damian; Carina Wattmo; Lucrezia Hausner; Roger Bullock; Peter J Connelly; Bruno Dubois; Maria Eriksdotter; Michael Ewers; Elmar Graessel; Milica G Kramberger; Emma Law; Patrizia Mecocci; José L Molinuevo; Louise Nygård; Marcel Gm Olde-Rikkert; Jean-Marc Orgogozo; Florence Pasquier; Karine Peres; Eric Salmon; Sietske Am Sikkes; Tomasz Sobow; René Spiegel; Magda Tsolaki; Bengt Winblad; Lutz Frölich
Journal:  Alzheimers Res Ther       Date:  2015-03-18       Impact factor: 6.982

Review 10.  Role of homocysteine in the development of cardiovascular disease.

Authors:  Paul Ganguly; Sreyoshi Fatima Alam
Journal:  Nutr J       Date:  2015-01-10       Impact factor: 3.271

View more
  11 in total

1.  Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.

Authors:  Jingchuan Guo; Karen A Nunley; Tina Costacou; Rachel G Miller; Caterina Rosano; Daniel Edmundowicz; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2018-11-08       Impact factor: 5.162

Review 2.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

3.  Lipopolysaccharide exposure in a rat sepsis model results in hippocampal amyloid-β plaque and phosphorylated tau deposition and corresponding behavioral deficits.

Authors:  Ryan A Kirk; Raymond P Kesner; Li-Ming Wang; Qi Wu; Rheal A Towner; John M Hoffman; Kathryn A Morton
Journal:  Geroscience       Date:  2019-08-31       Impact factor: 7.713

Review 4.  Nrf2 dysfunction and impaired cellular resilience to oxidative stressors in the aged vasculature: from increased cellular senescence to the pathogenesis of age-related vascular diseases.

Authors:  Zoltan Ungvari; Stefano Tarantini; Ádám Nyúl-Tóth; Tamas Kiss; Andriy Yabluchanskiy; Tamas Csipo; Priya Balasubramanian; Agnes Lipecz; Zoltan Benyo; Anna Csiszar
Journal:  Geroscience       Date:  2019-10-26       Impact factor: 7.713

Review 5.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

6.  Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway.

Authors:  So Yamamoto; Tomoko Kayama; Moeko Noguchi-Shinohara; Tsuyoshi Hamaguchi; Masahito Yamada; Keiko Abe; Shoko Kobayashi
Journal:  NPJ Sci Food       Date:  2021-01-29

7.  1H NMR Urinary Metabolomic Analysis in Older Adults after Hip Fracture Surgery May Provide Valuable Information for Patient Profiling-A Preliminary Investigation.

Authors:  Wafa Douzi; Delphine Bon; Sara Suikkanen; Paula Soukkio; Nadège Boildieu; Arja Nenonen; Markku Hupli; Katriina Kukkonen-Harjula; Benoit Dugué
Journal:  Metabolites       Date:  2022-08-12

8.  Muscle weakness is a prognostic indicator of disability and chronic disease multimorbidity.

Authors:  Mark D Peterson; Kimberly Casten; Stacey Collins; Halimah Hassan; Antonio García-Hermoso; Jessica Faul
Journal:  Exp Gerontol       Date:  2021-07-02       Impact factor: 4.253

9.  Age-related alterations in the cerebrovasculature affect neurovascular coupling and BOLD fMRI responses: Insights from animal models of aging.

Authors:  Andriy Yabluchanskiy; Adam Nyul-Toth; Anna Csiszar; Rafal Gulej; Debra Saunders; Rheal Towner; Monroe Turner; Yuguang Zhao; Dema Abdelkari; Bart Rypma; Stefano Tarantini
Journal:  Psychophysiology       Date:  2020-11-03       Impact factor: 4.348

10.  TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model.

Authors:  Frank Zamudio; Anjanet R Loon; Shayna Smeltzer; Khawla Benyamine; Nanda K Navalpur Shanmugam; Nicholas J F Stewart; Daniel C Lee; Kevin Nash; Maj-Linda B Selenica
Journal:  J Neuroinflammation       Date:  2020-09-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.